Literature DB >> 11740216

Prevention of early postoperative hypotony by partial ligation of silicone tube in Ahmed glaucoma valve implantation.

C Kee1.   

Abstract

PURPOSE: To determine the effectiveness of the partial ligation of a silicone tube of Ahmed glaucoma valve implantation to prevent early postoperative hypotony. PATIENTS AND METHODS: Thirty-two Korean patients were divided into two groups. Ahmed glaucoma valve implantation was performed with or without partial ligation in 16 eyes. The incidence of complications and the success rate in each group were compared.
RESULTS: In the partial-ligation group, 10 patients (62.5%) had successful intraocular pressure control (> 5 to < 22 mm Hg) without any additional antiglaucoma medications, whereas intraocular pressure in 12 patients (75.0%) was controlled with or without additional antiglaucoma medications. In the nonligation group, nine patients (56.3%) had successful intraocular pressure control without any additional medications, whereas intraocular pressure in 12 patients (75.0%) was controlled with or without additional antiglaucoma medications. Early postoperative hypotony occurred in 1 of 16 (6.3%) patients with partial ligation and 4 of 16 (25%) patients without ligation.
CONCLUSION: The partial ligation of a tube in Ahmed glaucoma valve implantation suggested a lower rate of hypotony and surgical complications. There was no significant difference in final success rate between the partial ligation and nonligation groups.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11740216     DOI: 10.1097/00061198-200112000-00005

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  17 in total

Review 1.  Aqueous shunts for glaucoma.

Authors:  D S Minckler; S S Vedula; T J Li; M C Mathew; R S Ayyala; B A Francis
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

2.  Intraoperative testing of opening and closing pressure predicts risk of low intraocular pressure after Ahmed glaucoma valve implantation.

Authors:  F Bochmann; A Kipfer; J Tarantino; C Kaufmann; L Bachmann; M Thiel
Journal:  Eye (Lond)       Date:  2014-07-25       Impact factor: 3.775

3.  Histological findings of failed gold micro shunts in primary open-angle glaucoma.

Authors:  Luca Agnifili; Ciro Costagliola; Michele Figus; Giovanna Iezzi; Adriano Piattelli; Paolo Carpineto; Rodolfo Mastropasqua; Marco Nardi; Leonardo Mastropasqua
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-23       Impact factor: 3.117

Review 4.  Aqueous shunts for glaucoma.

Authors:  Victoria L Tseng; Anne L Coleman; Melinda Y Chang; Joseph Caprioli
Journal:  Cochrane Database Syst Rev       Date:  2017-07-28

5.  Intraocular pressure control of a novel glaucoma drainage device - in vitro and in vivo studies.

Authors:  Li-Jun Cui; Di-Chen Li; Jian Liu; Lei Zhang; Yao Xing
Journal:  Int J Ophthalmol       Date:  2017-09-18       Impact factor: 1.779

6.  Pars plana-modified Ahmed Glaucoma Valve for treatment of refractory glaucoma: a pilot study.

Authors:  Torsten Schlote; Focke Ziemssen; Karl Ulrich Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-18       Impact factor: 3.117

Review 7.  Childhood glaucoma surgery in the 21st century.

Authors:  M Papadopoulos; B Edmunds; C Fenerty; P T Khaw
Journal:  Eye (Lond)       Date:  2014-06-13       Impact factor: 3.775

8.  Partial Tenon's capsule resection with adjunctive mitomycin C in Ahmed glaucoma valve implant surgery.

Authors:  R Susanna
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

9.  Laser Activated Flow Regulator for Glaucoma Drainage Devices.

Authors:  Jeffrey L Olson; Raul Velez-Montoya; Ramanath Bhandari
Journal:  Transl Vis Sci Technol       Date:  2014-11-03       Impact factor: 3.283

10.  Current surgical options for the management of pediatric glaucoma.

Authors:  Jose Morales; Sami Al Shahwan; Sami Al Odhayb; Ibrahim Al Jadaan; Deepak P Edward
Journal:  J Ophthalmol       Date:  2013-04-24       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.